|
1
|
Kay MA, Glorioso JC and Naldini L: Viral
vectors for gene therapy: The art of turning infectious agents into
vehicles of therapeutics. Nat Med. 7:33–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Naldini L, Blömer U, Gallay P, Ory D,
Mulligan R, Gage FH, Verma IM and Trono D: In vivo gene delivery
and stable transduction of nondividing cells by a lentiviral
vector. Science. 272:263–267. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jaleco AC, Stegmann AP, Heemskerk MH,
Couwenberg F, Bakker AQ, Weijer K and Spits H: Genetic modification
of human B-cell development: B-cell development is inhibited by the
dominant negative helix loop helix factor Id3. Blood. 94:2637–2646.
1999.PubMed/NCBI
|
|
4
|
Serafini M, Naldini L and Introna M:
Molecular evidence of inefficient transduction of proliferating
human B lymphocytes by VSV-pseudotyped HIV-1-derived lentivectors.
Virology. 325:413–424. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kvell K, Nguyen TH, Salmon P, Glauser F,
Werner-Favre C, Barnet M, Schneider P, Trono D and Zubler RH:
Transduction of CpG DNA-stimulated primary human B cells with
bicistronic lentivectors. Mol Ther. 12:892–899. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Janssens W, Chuah MK, Naldini L, Follenzi
A, Collen D, Saint-Remy JM and VandenDriessche T: Efficiency of
onco-retroviral and lentiviral gene transfer into primary mouse and
human B-lymphocytes is pseudotype dependent. Hum Gene Ther.
14:263–276. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang L, Bailey L, Baltimore D and Wang P:
Targeting lentiviral vectors to specific cell types in vivo. Proc
Natl Acad Sci USA. 103:11479–11484. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Burns JC, Friedmann T, Driever W,
Burrascano M and Yee JK: Vesicular stomatitis virus G glycoprotein
pseudotyped retroviral vectors: Concentration to very high titer
and efficient gene transfer into mammalian and nonmammalian cells.
Proc Natl Acad Sci USA. 90:8033–8037. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Finkelshtein D, Werman A, Novick D, Barak
S and Rubinstein M: LDL receptor and its family members serve as
the cellular receptors for vesicular stomatitis virus. Proc Natl
Acad Sci USA. 110:7306–7311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Amirache F, Lévy C, Costa C, Mangeot PE,
Torbett BE, Wang CX, Nègre D, Cosset FL and Verhoeyen E: Mystery
solved: VSV-G-LVs do not allow efficient gene transfer into
unstimulated T cells, B cells, and HSCs because they lack the LDL
receptor. Blood. 123:1422–1424. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Frecha C, Costa C, Lévy C, Nègre D,
Russell SJ, Maisner A, Salles G, Peng KW, Cosset FL and Verhoeyen
E: Efficient and stable transduction of resting B lymphocytes and
primary chronic lymphocyte leukemia cells using measles virus gp
displaying lentiviral vectors. Blood. 114:3173–3180. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Frecha C, Lévy C, Costa C, Nègre D,
Amirache F, Buckland R, Russell SJ, Cosset FL and Verhoeyen E:
Measles virus glycoprotein-pseudotyped lentiviral vector-mediated
gene transfer into quiescent lymphocytes requires binding to both
SLAM and CD46 entry receptors. J Virol. 85:5975–5985. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Funke S, Maisner A, Mühlebach MD, Koehl U,
Grez M, Cattaneo R, Cichutek K and Buchholz CJ: Targeted cell entry
of lentiviral vectors. Mol Ther. 16:1427–1436. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dörig RE, Marcil A, Chopra A and
Richardson CD: The human CD46 molecule is a receptor for measles
virus (Edmonston strain). Cell. 75:295–305. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tatsuo H, Ono N, Tanaka K and Yanagi Y:
SLAM (CDw150) is a cellular receptor for measles virus. Nature.
406:893–897. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sambrook J, Fritsch EF and Maniatis T:
Molecular Cloning: A laboratory manual. 2nd. Cold Spring Harbor
Laboratory Press; Cold Spring Harbor, NY: pp. 1.63–1.70. 1989
|
|
17
|
Bovia F, Salmon P, Matthes T, Kvell K,
Nguyen TH, Werner-Favre C, Barnet M, Nagy M, Leuba F, Arrighi JF,
et al: Efficient transduction of primary human B lymphocytes and
nondividing myeloma B cells with HIV-1-derived lentiviral vectors.
Blood. 101:1727–1733. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Heath E, Begue-Pastor N, Chaganti S,
Croom-Carter D, Shannon-Lowe C, Kube D, Feederle R, Delecluse HJ,
Rickinson AB and Bell AI: Epstein-Barr virus infection of naïve B
cells in vitro frequently selects clones with mutated
immunoglobulin genotypes: Implications for virus biology. PLoS
Pathog. 8:e10026972012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Joseph AM, Babcock GJ and Thorley-Lawson
DA: EBV persistence involves strict selection of latently infected
B cells. J Immunol. 165:2975–2981. 2000. View Article : Google Scholar : PubMed/NCBI
|
